The present invention relates to compounds of the Formula ##STR00001## or
a pharmaceutically acceptable salt, solvate, hydrate or formulation
thereof. These compounds can be used for the inhibition of Factor Xa and
for the treatment and/or prevention of diseases that are mediated by
Factor Xa activity.